Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dirce Maria Carraro is active.

Publication


Featured researches published by Dirce Maria Carraro.


Current Genetics | 2004

Structural features and transcript-editing analysis of sugarcane (Saccharum officinarum L.) chloroplast genome

Tercilio Calsa Júnior; Dirce Maria Carraro; Matheus R. Benatti; Alexandre Corrêa Barbosa; João Paulo Kitajima; Helaine Carrer

The complete nucleotide sequence of the chloroplast genome of sugarcane (Saccharum officinarum) was determined. It consists of 141,182 base-pairs (bp), containing a pair of inverted repeat regions (IRA, IRB) of 22,794xa0bp each. The IRA and IRB sequences separate a small single copy region (12,546xa0bp) and a large single copy (83,048xa0bp) region. The gene content and relative arrangement of the 116 identified genes (82 peptide-encoding genes, four ribosomal RNA genes, 30xa0tRNA genes), with the 16 ycf genes, are highly similar to maize. Editing events, defined as C-to-U transitions in the mRNA sequences, were comparable with those observed in maize, rice and wheat. The conservation of gene organization and mRNA editing suggests a common ancestor for the sugarcane and maize plastomes. These data provide the basis for functional analysis of plastid genes and plastid metabolism within the Poaceae. The sugarcane chloroplast DNA sequence is available at GenBank under accession NC005878.


Fems Microbiology Letters | 2003

Expression of putative pathogenicity-related genes in Xylella fastidiosa grown at low and high cell density conditions in vitro

Leandra M. Scarpari; Marcio R. Lambais; Denise dos Santos Silva; Dirce Maria Carraro; Helaine Carrer

Xylella fastidiosa is the causal agent of economically important plant diseases, including citrus variegated chlorosis and Pierces disease. Hitherto, there has been no information on the molecular mechanisms controlling X. fastidiosa-plant interactions. To determine whether predicted open reading frames (ORFs) encoding putative pathogenicity-related factors were expressed by X. fastidiosa 9a5c cells grown at low (LCD) and high cell density (HCD) conditions in liquid modified PW medium, reverse Northern blot hybridization and reverse transcription-polymerase chain reaction (RT-PCR) experiments were performed. Our results indicated that ORFs XF2344, XF2369, XF1851 and XF0125, encoding putative Fur, GumC, a serine-protease and RsmA, respectively, were significantly suppressed at HCD conditions. In contrast, ORF XF1115, encoding putative RpfF, was significantly induced at HCD conditions. Expressions of ORFs XF2367, XF2362 and XF0290, encoding putative GumD, GumJ and RpfA, respectively, were detected only at HCD conditions, whereas expression of ORF XF0287, encoding putative RpfB was detected only at LCD conditions. Bioassays with an Agrobacterium traG::lacZ reporter system indicated that X. fastidiosa does not synthesize N-acyl-homoserine lactones, whereas bioassays with a diffusible signal factor (DSF)-responsive Xanthomonas campestris pv. campestris mutant indicate that X. fastidiosa synthesizes a molecule similar to DSF in modified PW medium. Our data also suggest that the synthesis of the DSF-like molecule and fastidian gum by X. fastidiosa is affected by cell density in vitro.


Archive | 2007

From Tissue Samples to Tumor Markers

Dirce Maria Carraro; Helena Brentani; Fernando Augusto Soares; Luiz F. L. Reis; Ricardo R. Brentani

Changes in the general transcription profile have been observed through silencing and activating at the transcriptional level of genes in tumor cells. After the genomic era, molecular biology has changed, and new technologies have allowed assessing transcriptional alterations among different tissue types in a high-throughput manner. Microarray technology is one of the technologies that has contributed to improving our understanding about the defective molecular processes in cancer cells. In this chapter, we report issues about the selection of cDNA clones spotted on the platform, the purity of the tumor samples used in the microarray experiments, and the integrated database with important clinical information of patients that can be associated to a specific molecular portrait. Finally, we focus on the validation of candidate genes selected from microarray experiments through real-time RT-PCR and high-throughput tissue microarray analyses that dramatically facilitate testing of the potential molecular markers.


BMC Proceedings | 2013

Gene expression profile of stromal cells from potential metastatic sites in breast cancer patients.

Paulo Roberto Del Valle; M. L.H. Katayama; Dirce Maria Carraro; Renato Puga; Eduardo Carneiro de Lyra; Cintia Milani; Patricia Bortman Rozenchan; Maria Mitzi Brentani; M.A.A.K. Folgueira

Methods Fibroblasts primary culture was established from 11 breast cancer patients. Expression analysis was evaluated in PT (n=4), N+ (n=3) and BM (n=4) through a customized cDNA microarray platform (4,800 ORESTES) analyzed by SAM (TMEV; FDR 0%) and functional analysis was performed using DAVID. Technical validation was performed in 6 samples and biological validation was performed in fibroblasts obtained from others 25 patients as evaluated by RT-qPCR.


BMC Proceedings | 2013

Genome-wide profiling of copy number alterations in triple-negative breast cancer identifies a region at 19p13 associated with lymph node metastasis

Felipe Fidalgo; Amanda Gonçalves; Tatiane Cristina Rodrigues; Alex Fiorini; Dirce Maria Carraro; Carla Rosenberg; Ana Cristina Victorino Krepischi

Background The acquisition of somatic alterations (point mutations/ chromosomal rearrangements) underlies the hallmarks of cancer, generating genetic diversity that drives tumorigenesis. Advances in the study of cancer genomes revealed in solid tumors a complex pattern of copy number alterations (CNA), structural rearrangements, and aneuplodies. Breast cancer (BC) is the most common malignancy in females, being the leading cause of death by cancer. This heterogeneous disease is not fully understood yet; however, genomic studies have identified unique CNA patterns in different BC subtypes. Regarding the subtype triple-negative (TN; estrogen and progesterone receptors, and HER2 negative expression levels), only limited data are available on which genes or chromosome regions are involved in its initiation and progression.


Oncoscience | 2015

RAS mutations vary between lesions in synchronous primary colorectal cancer: testing only one lesion is not sufficient to guide anti-EGFR treatment decisions

Mariana Petaccia de Macedo; Fernanda Machado de Melo; Júlia da Silva Silva Ribeiro; Celso Abdon Lopes de Mello; Maria Dirlei Begnami; Fernando Augusto Soares; Dirce Maria Carraro; Isabela Werneck da Cunha


Epigenomes | 2017

Mining Novel Candidate Imprinted Genes Using Genome-Wide Methylation Screening and Literature Review

Adriano Bonaldi; André Y. Kashiwabara; Érica Sara Souza de Araújo; Lygia V. Pereira; Alexandre R. Paschoal; Mayra B. Andozia; Darine Villela; Maria P. Rivas; Claudia Kimie Suemoto; Carlos Augusto Pasqualucci; Lea T. Grinberg; Helena Brentani; Silvya Stuchi Maria-Engler; Dirce Maria Carraro; Angela M. Vianna-Morgante; Carla Rosenberg; Luciana R. Vasques; Ana C.V. Krepischi


Archive | 2012

Down-regulation of ANAPC13 and CLTCL1: Early Events in the Progression of Preinvasive Ductal

Carolina Sens-Abuázar; Elisa Napolitano; Cynthia Aparecida Bueno; Toledo Osório; Ana Cristina; Victorino Krepischi; Tatiana Iervolino Ricca; Nadia P. Castro; Isabela Werneck da Cunha; Maria do Socorro Maciel; Carla Rosenberg; Maria Mitzi Brentani; Fernando Augusto Soares; Rafael Malagoli Rocha; Dirce Maria Carraro; A. C. Camargo


Archive | 2009

Epigenetic Silencing of CRABP2 and MX1 in

Marilia de Freitas Calmon; Rodrigo V. Rodrigues; Carla M. Kaneto; Ricardo Moura; Sabrina D. Silva; Louise Danielle; C. Mota; Daniel G. Pinheiro; Cesar Torres; Alex F. Carvalho; M. Cury; Fabio Daumas Nunes; Nobuko Nishimoto; Fernando Augusto Soares; L.P. Kowalski; Helena Brentani; Cleslei Fernando Zanelli; A. S. Silva; Paula Rahal; Eloiza Helena Tajara; Dirce Maria Carraro; Sandro Roberto Valentini


Cancer Epidemiology and Prevention Biomarkers | 2007

The fight against cancer takes the metro: Cancer prevention campaign in Sao Paulo subway system, Brazil

Mariana Marques; Cíntia R. Bombardieri; Dirce Maria Carraro; Ana L. B. Cintra; Patrícia Gravito Costa; Guilherme Francisco; Juliana S. Kuribayashi; Patricia Possik; Marcia Triunfol

Collaboration


Dive into the Dirce Maria Carraro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Helaine Carrer

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carla Rosenberg

National Institute of Standards and Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge